Search - tctmd.com

Displaying 101 - 120 of 1666

Sort: Relevancy | Date

Presentation NY Valves 2025

Trisol Valve Treating Patients With Severe RV Disfunction

Presenter: Kashish Goel

June 26, 2025

Presentation NY Valves 2025

Outcomes of Transcatheter Tricuspid Valve Replacement Across Devices: A Comprehensive Pooled Analysis

Presenter: Taha Hatab

June 26, 2025

Presentation NY Valves 2025

30-Day TRINITY Trial Outcomes in Large-Anatomies Patients Using LuX-Valve Plus Transjugular Tricuspid Valve Replacement System

Presenter: Thomas Elie Modine

June 26, 2025

Presentation NY Valves 2025

Initial Results From the International Multi-Center Internal Jugular (IJ) Evoque Valve Registry

Presenter: Brian P. O'Neill

June 26, 2025

Presentation NY Valves 2025

Right Valve, Wrong Fix: Decoding Persistent Tricuspid Regurgitation Post Valve-in-Ring

Presenter: Abdelrahman Ahmed

June 26, 2025

Presentation NY Valves 2025

Predicting Futility in Tricuspid Valve Interventions

Presenter: Volker Rudolph

June 26, 2025

Presentation NY Valves 2025

Is There a Rebound Favoring Surgery for Severe TR… Or Is RHF Still an Exclusion

Presenter: Robert L. Smith

June 26, 2025

Presentation NY Valves 2025

Tricuspid Valve-In-Evoque

Presenter: Jubin Joseph

June 26, 2025

Presentation NY Valves 2025

What Is the Role of Heterotopic Valves for Refractory TR Patients

Presenter: Alexander Lauten

June 26, 2025

Presentation NY Valves 2025

Trends and Outcomes of Cardiogenic Shock in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair: A U.S. National Analysis

Presenter: Salman Zahid

June 26, 2025

Presentation NY Valves 2025

Does Right Heart Ventricular Function Impact Device Choices in TTVI?

Presenter: Carlos E. Sanchez

June 26, 2025

Presentation NY Valves 2025

Transcatheter Implantation of SAPIEN 3 Ultra Resilia Valve in Native Tricuspid Valve

Presenter: Curtiss T. Stinis

June 26, 2025

Presentation NY Valves 2025

Differential Mechanism of Annuloplasty for Functional Mitral Regurgitation Versus Functional Tricuspid Regurgitation

Presenter: Matthew Kazaleh

June 26, 2025

Presentation NY Valves 2025

Impact of Frailty on Outcomes After Transcatheter Edge-to-Edge Repair (TTEER) From the National Inpatient Sample 2021–2022

Presenter: Mustafa Shehzad

June 26, 2025

Presentation NY Valves 2025

Transcatheter Treatment of Tricuspid Regurgitation due to Dehiscence of a Surgical Ring: Combining Intra- and Para-Valvular Approaches

Presenter: Alan Wong

June 26, 2025

Presentation NY Valves 2025

The Importance of Hemodynamic Profiling (Including PV Loops)

Presenter: Michael I. Brener

June 26, 2025

Presentation NY Valves 2025

Intraprocedural Optimization of Tricuspid TEER

Presenter: Edwin Ho

June 26, 2025

Presentation NY Valves 2025

How Many Clinical Phenotypes?

Presenter: Dharam J. Kumbhani

June 26, 2025

Presentation NY Valves 2025

Concomitant vs. Staged Mitral and Tricuspid Edge-to-Edge Repair: The COMMITTEE Study

Presenter: Antonio Sisinni

June 26, 2025

Presentation NY Valves 2025

Treatment Implications of Tricuspid Regurgitation in Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Mitsunobu Kitamura

June 26, 2025

Advertisement

Trisol Valve Treating Patients With Severe RV Disfunction

Outcomes of Transcatheter Tricuspid Valve Replacement Across Devices: A Comprehensive Pooled Analysis

30-Day TRINITY Trial Outcomes in Large-Anatomies Patients Using LuX-Valve Plus Transjugular Tricuspid Valve Replacement System

Initial Results From the International Multi-Center Internal Jugular (IJ) Evoque Valve Registry

Right Valve, Wrong Fix: Decoding Persistent Tricuspid Regurgitation Post Valve-in-Ring

Predicting Futility in Tricuspid Valve Interventions

Is There a Rebound Favoring Surgery for Severe TR… Or Is RHF Still an Exclusion

Tricuspid Valve-In-Evoque

What Is the Role of Heterotopic Valves for Refractory TR Patients

Trends and Outcomes of Cardiogenic Shock in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair: A U.S. National Analysis

Does Right Heart Ventricular Function Impact Device Choices in TTVI?

Transcatheter Implantation of SAPIEN 3 Ultra Resilia Valve in Native Tricuspid Valve

Differential Mechanism of Annuloplasty for Functional Mitral Regurgitation Versus Functional Tricuspid Regurgitation

Impact of Frailty on Outcomes After Transcatheter Edge-to-Edge Repair (TTEER) From the National Inpatient Sample 2021–2022

Transcatheter Treatment of Tricuspid Regurgitation due to Dehiscence of a Surgical Ring: Combining Intra- and Para-Valvular Approaches

The Importance of Hemodynamic Profiling (Including PV Loops)

Intraprocedural Optimization of Tricuspid TEER

How Many Clinical Phenotypes?

Concomitant vs. Staged Mitral and Tricuspid Edge-to-Edge Repair: The COMMITTEE Study

Treatment Implications of Tricuspid Regurgitation in Patients With Heart Failure With Reduced Ejection Fraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content